Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 5
1988 2
1989 1
1990 2
1992 2
1993 1
1994 2
1995 1
1996 1
2001 1
2002 1
2003 1
2004 1
2005 9
2006 13
2007 6
2008 4
2009 4
2010 3
2011 2
2012 3
2013 2
2014 3
2015 1
2018 1
2019 1
2020 1
2021 3
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial.
Watanabe H, Morimoto T, Natsuaki M, Yamamoto K, Obayashi Y, Ogita M, Suwa S, Isawa T, Domei T, Yamaji K, Tatsushima S, Watanabe H, Ohya M, Tokuyama H, Tada T, Sakamoto H, Mori H, Suzuki H, Nishikura T, Wakabayashi K, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Morino Y, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 ACS Investigators. Watanabe H, et al. JAMA Cardiol. 2022 Apr 1;7(4):407-417. doi: 10.1001/jamacardio.2021.5244. JAMA Cardiol. 2022. PMID: 35234821 Free PMC article. Clinical Trial.
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Domei T, Suwa S, Ogita M, Isawa T, Takenaka H, Yamamoto T, Ishikawa T, Hisauchi I, Wakabayashi K, Onishi Y, Hibi K, Kawai K, Yoshida R, Suzuki H, Nakazawa G, Kusuyama T, Morishima I, Ono K, Kimura T. Natsuaki M, et al. Among authors: kusuyama t. Circulation. 2024 Feb 20;149(8):585-600. doi: 10.1161/CIRCULATIONAHA.123.066720. Epub 2023 Nov 23. Circulation. 2024. PMID: 37994553 Clinical Trial.
Resolution of vocal fold polyps with conservative treatment.
Nakagawa H, Miyamoto M, Kusuyama T, Mori Y, Fukuda H. Nakagawa H, et al. Among authors: kusuyama t. J Voice. 2012 May;26(3):e107-10. doi: 10.1016/j.jvoice.2011.07.005. Epub 2011 Nov 13. J Voice. 2012. PMID: 22082864
Cough syncope induced by gastroesophageal reflux disease.
Kusuyama T, Iida H, Kino N, Shimodozono S, Kanazawa Y. Kusuyama T, et al. J Cardiol. 2009 Oct;54(2):300-3. doi: 10.1016/j.jjcc.2008.11.007. Epub 2009 Jan 14. J Cardiol. 2009. PMID: 19782269 Free article.
Effects of erythropoietin on cardiac remodeling after myocardial infarction.
Nishiya D, Omura T, Shimada K, Matsumoto R, Kusuyama T, Enomoto S, Iwao H, Takeuchi K, Yoshikawa J, Yoshiyama M. Nishiya D, et al. Among authors: kusuyama t. J Pharmacol Sci. 2006 May;101(1):31-9. doi: 10.1254/jphs.fp0050966. J Pharmacol Sci. 2006. PMID: 16717399 Free article.
The effects of HMG-CoA reductase inhibitor on vascular progenitor cells.
Kusuyama T, Omura T, Nishiya D, Enomoto S, Matsumoto R, Murata T, Takeuchi K, Yoshikawa J, Yoshiyama M. Kusuyama T, et al. J Pharmacol Sci. 2006 Aug;101(4):344-9. doi: 10.1254/jphs.fp0060102. Epub 2006 Aug 5. J Pharmacol Sci. 2006. PMID: 16891763 Free article.
70 results